Third Harmonic Bio, Inc. (THRD) Analyst Estimates Annual - Discounting Cash Flows
THRD
Third Harmonic Bio, Inc.
THRD (NASDAQ)
Period Ending: 2029
12-31
2028
12-31
2027
12-31
2026
12-31
2025
12-31
2024
12-31
2023
12-31
Number of Analysts 0 0 0 0 0 0 0
Estimated Revenue
Low 0 0 0 0 0 0 0
Average 0 0 0 0 0 0 0
High 0 0 0 0 0 0 0
Estimated EBITDA
Low 0 0 0 0 0 0 0
Average 0 0 0 0 0 0 0
High 0 0 0 0 0 0 0
Estimated EBIT
Low 0 0 0 0 0 0 0
Average 0 0 0 0 0 0 0
High 0 0 0 0 0 0 0
Estimated Net Income
Low -46.74 -39.64 -60.18 -40.9 -40.52 -53.06 -44.08
Average -46.74 -39.64 -59.26 -40.69 -36.64 -47.24 -44.08
High -46.74 -39.64 -58.34 -40.47 -32.76 -41.41 -44.08
Estimated SGA Expenses
Low 0 0 0 0 0 0 0
Average 0 0 0 0 0 0 0
High 0 0 0 0 0 0 0
Estimated EPS
Low -1.12 -0.95 -1.44 -0.98 -0.971 -1.27 -1.11
Average -1.12 -0.95 -1.42 -0.975 -0.875 -1.15 -1.11
High -1.12 -0.95 -1.4 -0.97 -0.785 -0.992 -1.11
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program